Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Reuters NewMedia - December 25, 2006
Circumcision has emerged as a new tool in the battle against AIDS following results in three African studies which showed it cuts the chances of HIV infection by as much as 60 percent.
Researchers who conducted one of the studies in Orange Farm outside of Johannesburg concluded that circumcising 1,000 men would prevent an estimated 300 new HIV infections over 20 years -- translating into savings of some $2.4 million that would have been spent on treating AIDS patients in this group alone.
"I would say we're making two points -- it's an effective strategy and it's cost effective," said James Kahn of the University of California-San Francisco, one of the researchers on the project.
The study in the medical journal PLoS Medicine has implications for other African countries, Kahn said.
"The estimate is that a fully scaled-up program might save ... well over $5 billion in savings if it were done throughout sub-Saharan Africa based on the infections prevented over 10 years," he said.
While researchers have hailed the circumcision studies as opening a new front in the war on AIDS, some African governments have reacted cautiously -- noting that it appears to provide only partial protection against HIV.
Public health experts have also warned that promoting circumcision may confuse or undercut other AIDS prevention strategies such as condom use and reducing a person's number of sexual partners.
Khan said however that, on a cost basis, circumcision was a good idea for Africa.
"HIV is particularly attractive (for finding cost savings) mainly because it's so serious a disease and so expensive to treat," he said. "But male circumcision looks pretty good compared to many other strategies that we use for HIV prevention."
***
additional reporting by Will Dunham in Washington
061225
RE061249
Copyright © 2006 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .